Who Should Avoid Lamivudine?
Very few people. The main restriction is about what it should not be combined with rather than who cannot take it.
Ask for everything you are eligible for in the same appointment. Repeat journeys are why most courses go unfinished.
Very few people. The main restriction is about what it should not be combined with rather than who cannot take it.
Most people, in current UK practice. It has a narrow remaining role and better alternatives exist for almost everyone.
Free advice exists for every route, and the useful move is getting it early rather than after you have a complete case.
Health systems differ across the four nations, and most of the organisations on this site work across all of them.
Ask for someone else, go elsewhere, and complain. Open access means a poor service does not have to be the end of it.
Anyone on interacting medicines, anyone who cannot attend reliably, and anyone with a detectable viral load starting…
Anyone on a contraindicated medicine, anyone pregnant, and anyone whose life makes the interaction burden unmanageable.
Almost nothing, which is a large part of why it appears in so many regimens. One rule matters absolutely.
No. The risk depends entirely on what prevention is in place, and two of the available options remove HIV from the picture…
A short list, dominated by other drugs that suppress the bone marrow and by two antiretrovirals it must never meet.
A short list dominated by tuberculosis treatment, with the complication that an injected drug cannot simply be stopped.
Charity registration, professional registers and a few warning signs. Most of it takes two minutes to verify.
When one of you says so. Waiting for it to declare itself is how people end up in arrangements neither of them chose.